Prostate-specific antigen follow-up and management for patients undergoing holmium laser enucleation of the prostate.
Shingo KimuraHiromichi KatayamaEiichiro OharaHiroshi AokiRie ShibuyaHiroshi NaganumaShigeto IshidoyaAkihiro ItoPublished in: International journal of urology : official journal of the Japanese Urological Association (2023)
Patients undergoing HoLEP are associated with some risk of potential PCa. While oncological outcomes were favorable among PCa-Ope, postoperative PSA should be carefully monitored even if not diagnosed with PCa with HoLEP specimen. Enucleation efficiency should be also considered not to misread pPSA value.